MOZOBIL

Welcome to the Brand page for “MOZOBIL”, which is offered here for Pharmaceutical and medicinal preparations for the treatment of hiv, inflammation, arthritis, asthma, cancer, cell transplants and cell transplant rejection, organ transplants and organ transplant rejection, angiogenesis, multiple sclerosis, bacterial infection, peripheral blood stem cell mobilization, cardiovascular diseases, lymphoma, tissue regeneration, tissue repair, leukemia, drug-induced anemia, retrovirus, hematopoietic deficit resulting from chemotherapy or radiation therapy, elevation of white blood cells, and ophthalmic diseases, including age related macular degeneration and diabetic retinopathy;.

Its status is currently believed to be active. Its class is unavailable. “MOZOBIL” is believed to be currently owned by “Genzyme Corporation”.